Sparfloxacin
Generic Name: sparfloxacin
Manufactured by MYLAN. Dosage form: TABLET. Route: ORAL. Active ingredients: SPARFLOXACIN (200MG). Application: NDA020677.
Overview
Manufactured by MYLAN. Dosage form: TABLET. Route: ORAL. Active ingredients: SPARFLOXACIN (200MG). Application: NDA020677.
Dosage
Available as tablet for oral use.
Related Medications
Onion,anemone Pulsatilla, Phosphorus, Goldenseal, Calcium Sulfide, Sodium Chloride, Sulfur, Matricaria Chamomilla And Arabica Coffee Bean
onion,anemone pulsatilla, phosphorus, goldenseal, calcium sulfide, sodium chloride, sulfur, matricaria chamomilla and arabica coffee bean
Non-Standardized Food Allergenic Extract [EPC]
Relieves congestion, runny nose, sore throat, sneezing, cough, post nasal drip and occasional sleeplessness
Colon (suis), Intestine (suis)
colon (suis), intestine (suis)
PURPOSE: Provides specific sarcode support for the intestines.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Inavolisib
inavolisib
Kinase Inhibitor [EPC]
11 DESCRIPTION ITOVEBI contains inavolisib, a kinase inhibitor. The chemical name of inavolisib is (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide. Inavolisib is a white to off-white, greyish pink, greyish orange, or greyish yellow powder or powder with lumps. Inavolisib demonstrates pH-dependent aqueous solubility; the greatest solubility is at low pH, and solubility decreases with increasing pH.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.